Cargando…

Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016

Antibiotics are important for the treatment and prevention of invasive Haemophilus influenzae disease. Reduced susceptibility to clinically relevant drugs, except ampicillin, has been uncommon in the United States. Susceptibility of 700 invasive H. influenzae isolates, collected through population-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Potts, Caelin C., Rodriguez-Rivera, Lorraine D., Retchless, Adam C., Buono, Sean A., Chen, Alexander T., Marjuki, Henju, Blain, Amy E., Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241922/
https://www.ncbi.nlm.nih.gov/pubmed/35536039
http://dx.doi.org/10.1128/spectrum.02579-21
_version_ 1784737934437515264
author Potts, Caelin C.
Rodriguez-Rivera, Lorraine D.
Retchless, Adam C.
Buono, Sean A.
Chen, Alexander T.
Marjuki, Henju
Blain, Amy E.
Wang, Xin
author_facet Potts, Caelin C.
Rodriguez-Rivera, Lorraine D.
Retchless, Adam C.
Buono, Sean A.
Chen, Alexander T.
Marjuki, Henju
Blain, Amy E.
Wang, Xin
author_sort Potts, Caelin C.
collection PubMed
description Antibiotics are important for the treatment and prevention of invasive Haemophilus influenzae disease. Reduced susceptibility to clinically relevant drugs, except ampicillin, has been uncommon in the United States. Susceptibility of 700 invasive H. influenzae isolates, collected through population-based surveillance during 2016, was assessed for 15 antibiotics using broth microdilution, according to the CLSI guidelines; a subset of 104 isolates were also assessed for rifampin susceptibility using Etest. Genomes were sequenced to identify genes and mutations known to be associated with reduced susceptibility to clinically relevant drugs. A total of 508 (72.6%) had reduced susceptibility to at least one antibiotic and more than half of the isolates exhibited reduced susceptibility to only one (33.6%) or two (21.6%) antibiotic classes. All tested isolates were susceptible to rifampin, a chemoprophylaxis agent, and <1% (n = 3) of isolates had reduced susceptibility to third generation cephalosporins, which are recommended for invasive disease treatment. In contrast, ampicillin resistance was more common (28.1%) and predominantly associated with the detection of a β-lactamase gene; 26.2% of isolates in the collection contained either a TEM-1 or ROB-1 β-lactamase gene, including 88.8% of ampicillin-resistant isolates. β-lactamase negative ampicillin-resistant (BLNAR) isolates were less common and associated with ftsI mutations; resistance to amoxicillin-clavulanate was detected in <2% (n = 13) of isolates. The proportion of reduced susceptibility observed was higher among nontypeable H. influenzae and serotype e than other serotypes. US invasive H. influenzae isolates remain predominantly susceptible to clinically relevant antibiotics except ampicillin, and BLNAR isolates remain uncommon. IMPORTANCE Antibiotics play an important role for the treatment and prevention of invasive Haemophilus influenzae disease. Antimicrobial resistance survey of invasive H. influenzae isolates collected in 2016 showed that the US H. influenzae population remained susceptible to clinically relevant antibiotics, except for ampicillin. Detection of approximately a quarter ampicillin-resistant and β-lactamase containing strains demonstrates that resistance mechanisms can be acquired and sustained within the H. influenzae population, highlighting the continued importance of antimicrobial resistance surveillance for H. influenzae to monitor susceptibility trends and mechanisms of resistance.
format Online
Article
Text
id pubmed-9241922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-92419222022-06-30 Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016 Potts, Caelin C. Rodriguez-Rivera, Lorraine D. Retchless, Adam C. Buono, Sean A. Chen, Alexander T. Marjuki, Henju Blain, Amy E. Wang, Xin Microbiol Spectr Research Article Antibiotics are important for the treatment and prevention of invasive Haemophilus influenzae disease. Reduced susceptibility to clinically relevant drugs, except ampicillin, has been uncommon in the United States. Susceptibility of 700 invasive H. influenzae isolates, collected through population-based surveillance during 2016, was assessed for 15 antibiotics using broth microdilution, according to the CLSI guidelines; a subset of 104 isolates were also assessed for rifampin susceptibility using Etest. Genomes were sequenced to identify genes and mutations known to be associated with reduced susceptibility to clinically relevant drugs. A total of 508 (72.6%) had reduced susceptibility to at least one antibiotic and more than half of the isolates exhibited reduced susceptibility to only one (33.6%) or two (21.6%) antibiotic classes. All tested isolates were susceptible to rifampin, a chemoprophylaxis agent, and <1% (n = 3) of isolates had reduced susceptibility to third generation cephalosporins, which are recommended for invasive disease treatment. In contrast, ampicillin resistance was more common (28.1%) and predominantly associated with the detection of a β-lactamase gene; 26.2% of isolates in the collection contained either a TEM-1 or ROB-1 β-lactamase gene, including 88.8% of ampicillin-resistant isolates. β-lactamase negative ampicillin-resistant (BLNAR) isolates were less common and associated with ftsI mutations; resistance to amoxicillin-clavulanate was detected in <2% (n = 13) of isolates. The proportion of reduced susceptibility observed was higher among nontypeable H. influenzae and serotype e than other serotypes. US invasive H. influenzae isolates remain predominantly susceptible to clinically relevant antibiotics except ampicillin, and BLNAR isolates remain uncommon. IMPORTANCE Antibiotics play an important role for the treatment and prevention of invasive Haemophilus influenzae disease. Antimicrobial resistance survey of invasive H. influenzae isolates collected in 2016 showed that the US H. influenzae population remained susceptible to clinically relevant antibiotics, except for ampicillin. Detection of approximately a quarter ampicillin-resistant and β-lactamase containing strains demonstrates that resistance mechanisms can be acquired and sustained within the H. influenzae population, highlighting the continued importance of antimicrobial resistance surveillance for H. influenzae to monitor susceptibility trends and mechanisms of resistance. American Society for Microbiology 2022-05-10 /pmc/articles/PMC9241922/ /pubmed/35536039 http://dx.doi.org/10.1128/spectrum.02579-21 Text en Copyright © 2022 Potts et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Potts, Caelin C.
Rodriguez-Rivera, Lorraine D.
Retchless, Adam C.
Buono, Sean A.
Chen, Alexander T.
Marjuki, Henju
Blain, Amy E.
Wang, Xin
Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title_full Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title_fullStr Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title_full_unstemmed Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title_short Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
title_sort antimicrobial susceptibility survey of invasive haemophilus influenzae in the united states in 2016
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241922/
https://www.ncbi.nlm.nih.gov/pubmed/35536039
http://dx.doi.org/10.1128/spectrum.02579-21
work_keys_str_mv AT pottscaelinc antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT rodriguezriveralorrained antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT retchlessadamc antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT buonoseana antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT chenalexandert antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT marjukihenju antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT blainamye antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016
AT wangxin antimicrobialsusceptibilitysurveyofinvasivehaemophilusinfluenzaeintheunitedstatesin2016